In trading on Tuesday, shares of the MLP ETF (Symbol: MLPA) crossed below their 200 day moving average of $47.43, changing hands as low as $47.35 per share. MLP shares are currently trading down ...

What is the best career fit for me? Take our assessment now. Finding your dream job starts with knowing what makes you the way you are. Simple Statements that relate to you. Unique Be yourself ...

How Much Does a Dentist Make? Dentists made a median salary of $155,040 in 2022. The best-paid 25% made $212,220 that year, while the lowest-paid 25% made $105,480. The states and districts that ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

With phase 3 miss, Pfizer's DMD candidate is no threat to Sarepta's Elevidys ahead of key label expansion: analysts Elevidys’ third-quarter sales hit CHF 108 million, beating consensus estimates ...

The layoffs come three months after the company axed 150 positions in Sanford following a high-profile phase 3 trial failure for its Duchenne muscular dystrophy (DMD) gene therapy candidate.

The MLPA ETF does not issue a K-1 tax form, so investors are at least getting some tax-prep relief in return for the relatively stiff 0.45% expense fee. MLPA ETF's top-10 holdings show moderate ...

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Capricor Therapeutics has released more positive three-year safety and efficacy data from the Phase II HOPE-2 open-label extension (OLE) trial for its Duchenne muscular dystrophy (DMD) cell therapy, ...